EUVIMEDEUVIMED entdecken
Crossref

Hampered CD8 + ILT2 + T cell activation by HLA-G suggests a new immune checkpoint in gastric adenocarcinoma

Christian Vaquero-Yuste, Ignacio Juarez, Marta Molina-Alejandre, Alberto Gutiérrez-Calvo, Adela López-García, Inmaculada Lasa, Remedios Gómez, Antonio Arnaiz-Villena, José Manuel Martín-Villa iD

Gastric Cancer · 2026-01 · 29 (1) · 83-96

DOI: 10.1007/s10120-025-01689-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastric Cancer, online erschienen am 04.12.2025. Verfasst von Christian Vaquero-Yuste und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Inmunología, Oftalmología y ORL, Facultad de Medicina, Universidad Complutense de Madrid, Calle Doctor Severo Ochoa 9, Pabellón V, 4t…. Hauptthemen laut MEDLINE: Stomach Neoplasms, HLA-G Antigens, Adenocarcinoma, Lymphocyte Activation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Universidad Complutense de Madrid, Instituto de Salud Carlos III, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Immune checkpoint inhibitors (ICI) are pivotal in cancer treatment. However, not all patients are responsive to current ICI therapies, and new targets are needed. Thus, the HLA-G/ILT2 pathway emerges as one such potential ICI. The present study aimed to analyze the implications of this pathway in cytotoxic T cells from patients with gastric adenocarcinoma. METHODS: Peripheral blood mononuclear cells (PBMCs), and tissue infiltrating lymphocytes were obtained from 16 patients with gastric adenocarcinoma. PBMCs from 17 healthy subjects were used as controls. Cells were subjected to flow cytometry on the one hand and stimulation (assessed by IFNγ production) and proliferation assays, in the presence or absence of HLA-G, on the other. RESULTS: Despite lower CD3 + counts (p = 0.0036), CD3 + CD8 + ILT2 + (ILT2 + Tc) cells are overrepresented in patients, compared to control subjects (p < 0.0001). These ILT2 + Tc exhibit enhanced anti T-cell receptor (TCR)-stimulated IFNγ production, compared to its counterparts ILT2- Tc (p = 0.0039), which was impaired by the presence of HLA-G (p = 0.0002). Proliferative responses of Tc were significantly reduced by HLA-G (p < 0.0001) after 5 days of stimulation. Finally, simultaneously PD1 and ILT2 staining revealed differential expression patterns between patients. CONCLUSIONS: CD8 + T cells expressing ILT2 are overrepresented in patients with gastric adenocarcinoma, independent of PD-1 expression, and appear particularly susceptible to functional suppression in the presence of HLA-G-positive tumors. These findings highlight the immunomodulatory role of HLA-G in the tumor microenvironment and support its relevance as a potential target for personalized immunotherapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsHLA-G AntigensAdenocarcinomaLymphocyte ActivationCD8-Positive T-LymphocytesLeukocyte Immunoglobulin-like Receptor B1HumansMaleFemaleMiddle AgedAgedLymphocytes, Tumor-InfiltratingCase-Control StudiesAged, 80 and over

Stichwörter der Autor:innen

Gastric cancerHLA-GILT2 (LILRB1)Immune checkpoint inhibitorsImmunotherapy

Substanzen

HLA-G AntigensLeukocyte Immunoglobulin-like Receptor B1

Autor:innen und Institutionen

  • Departamento de Inmunología, Oftalmología y ORL, Facultad de Medicina, Universidad Complutense de Madrid, Calle Doctor Severo Ochoa 9, Pabellón V, 4th Floor, 28040, Madrid, Spain.
  • Servicio de Cirugía General y Aparato Digestivo, Hospital Universitario Príncipe de Asturias, Madrid, Spain.
  • Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
  • Departamento de Inmunología, Oftalmología y ORL, Facultad de Medicina, Universidad Complutense de Madrid, Calle Doctor Severo Ochoa 9, Pabellón V, 4th Floor, 28040, Madrid, Spain. jmmvilla@ucm.es.
  • Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. jmmvilla@ucm.es.

ORCID-Profile: José Manuel Martín-Villa

Förderung

  • Universidad Complutense de Madrid
  • Instituto de Salud Carlos III
  • European Regional Development Fund

Zitieren

APA

Vaquero-Yuste, C., Juarez, I., Molina-Alejandre, M., Gutiérrez-Calvo, A., López-García, A., Lasa, I., Gómez, R., Arnaiz-Villena, A., & Martín-Villa, J. M. (2026). Hampered CD8 + ILT2 + T cell activation by HLA-G suggests a new immune checkpoint in gastric adenocarcinoma. Gastric Cancer, 29(1), 83-96. https://doi.org/10.1007/s10120-025-01689-5

Vancouver

Vaquero-Yuste C, Juarez I, Molina-Alejandre M, Gutiérrez-Calvo A, López-García A, Lasa I, et al. Hampered CD8 + ILT2 + T cell activation by HLA-G suggests a new immune checkpoint in gastric adenocarcinoma. Gastric Cancer. 2026;29(1):83-96. doi:10.1007/s10120-025-01689-5

BibTeX
@article{VaqueroYuste2026,
  author = {Vaquero-Yuste, Christian and Juarez, Ignacio and Molina-Alejandre, Marta and Gutiérrez-Calvo, Alberto and López-García, Adela and Lasa, Inmaculada and Gómez, Remedios and Arnaiz-Villena, Antonio and Martín-Villa, José Manuel},
  title = {Hampered CD8 + ILT2 + T cell activation by HLA-G suggests a new immune checkpoint in gastric adenocarcinoma},
  journal = {Gastric Cancer},
  year = {2026},
  volume = {29},
  number = {1},
  pages = {83--96},
  doi = {10.1007/s10120-025-01689-5}
}
Kostenlos starten →